409 related articles for article (PubMed ID: 8950780)
1. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
Geng JP; Cheng CH; Castellino FJ
Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
[TBL] [Abstract][Full Text] [Related]
2. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
Geng JP; Castellino FJ
Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
[TBL] [Abstract][Full Text] [Related]
3. The functions of the first epidermal growth factor homology region of human protein C as revealed by a charge-to-alanine scanning mutagenesis investigation.
Cheng CH; Geng JP; Castellino FJ
Biol Chem; 1997 Dec; 378(12):1491-500. PubMed ID: 9461348
[TBL] [Abstract][Full Text] [Related]
4. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.
Jalbert LR; Chan JC; Christiansen WT; Castellino FJ
Biochemistry; 1996 Jun; 35(22):7093-9. PubMed ID: 8679535
[TBL] [Abstract][Full Text] [Related]
5. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
6. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
Dahlbäck B
Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
8. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins.
Geng JP; Castellino FJ
Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532
[TBL] [Abstract][Full Text] [Related]
9. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity.
Zhang L; Jhingan A; Castellino FJ
Blood; 1992 Aug; 80(4):942-52. PubMed ID: 1498334
[TBL] [Abstract][Full Text] [Related]
10. Functions of individual gamma-carboxyglutamic acid (Gla) residues of human protein c. Determination of functionally nonessential Gla residues and correlations with their mode of binding to calcium.
Christiansen WT; Tulinsky A; Castellino FJ
Biochemistry; 1994 Dec; 33(50):14993-5000. PubMed ID: 7999756
[TBL] [Abstract][Full Text] [Related]
11. Role of the hexapeptide disulfide loop in the gamma-carboxyglutamic acid domain of protein C in Ca2+-mediated structural and functional properties.
Dai Q; Prorok M; Castellino FJ
Biochemistry; 2005 Sep; 44(37):12508-14. PubMed ID: 16156662
[TBL] [Abstract][Full Text] [Related]
12. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.
Christiansen WT; Castellino FJ
Biochemistry; 1994 May; 33(19):5901-11. PubMed ID: 8180219
[TBL] [Abstract][Full Text] [Related]
13. EGF-like module pair 3-4 in vitamin K-dependent protein S: modulation of calcium affinity of module 4 by module 3, and interaction with factor X.
Stenberg Y; Muranyi A; Steen C; Thulin E; Drakenberg T; Stenflo J
J Mol Biol; 1999 Oct; 293(3):653-65. PubMed ID: 10543957
[TBL] [Abstract][Full Text] [Related]
14. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling.
Giri TK; Villoutreix BO; Wallqvist A; Dahlbäck B; de Frutos PG
Thromb Haemost; 1998 Nov; 80(5):798-804. PubMed ID: 9843174
[TBL] [Abstract][Full Text] [Related]
15. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma.
Krisinger MJ; Guo LJ; Salvagno GL; Guidi GC; Lippi G; Dahlbäck B
FEBS J; 2009 Nov; 276(22):6586-602. PubMed ID: 19817854
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va.
Gale AJ; Griffin JH
Proteins; 2004 Feb; 54(3):433-41. PubMed ID: 14747992
[TBL] [Abstract][Full Text] [Related]
17. Construction, expression, and properties of a recombinant chimeric human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX.
Yu S; Zhang L; Jhingan A; Christiansen WT; Castellino FJ
Biochemistry; 1994 Jan; 33(3):823-31. PubMed ID: 8292611
[TBL] [Abstract][Full Text] [Related]
18. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
19. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain.
Takamiya O
Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333
[TBL] [Abstract][Full Text] [Related]
20. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
Chang Y; Zajicek J; Castellino FJ
Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
